Direct interactions between platelets and cultured rat mesangial cells

Area of Science:

• Nephrology
• Hematology
• Cell Biology

Background:

• Platelets are implicated in kidney disease pathogenesis, but their precise role in renal function changes remains unclear.
• Understanding platelet interactions with kidney cells is crucial for deciphering disease mechanisms.

Purpose of the Study:

• To investigate the effect of platelet-derived factors on mesangial cells (MC).
• To identify specific platelet mediators responsible for observed cellular changes and their potential link to reduced glomerular filtration rate (GFR).

Main Methods:

• Mesangial cells were incubated with platelet supernatants (PS).
• Cellular surface area (CSA) and myosin light-chain phosphorylation (MLCP) were measured.
• Platelets were pretreated with indomethacin, thromboxane A2 (TXA2) receptor blocker (sulotroban), or platelet-activating factor (PAF) receptor blocker (BN-52021) to assess mediator roles.

Main Results:

• Platelet supernatants significantly reduced MC surface area and increased MLCP.
• Pretreatment of platelets with indomethacin, sulotroban, or BN-52021 abolished these effects.
• Thrombin activation of platelets inhibited the PS-induced contraction of MC.

Conclusions:

• Platelet supernatants induce mesangial cell contraction, potentially contributing to decreased GFR in certain kidney diseases.
• Thromboxane A2 and platelet-activating factor are key mediators of this platelet-induced mesangial cell response.
• Thrombin may exert a protective effect by inhibiting platelet-induced mesangial cell contraction.